[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hematoma\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hematoma":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,51,89],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":4},"100642717","prophylactic-use-of-cinpwt-in-gynecologic-laparotomy-100642717",false,"NCT07645547","Prophylactic Use of ciNPWT in Gynecologic Laparotomy","Implementation of Prophylactic Negative Pressure Wound Therapy (ciNPWT) in High-Risk Patients in Gynecologic Oncology: A Prospective Feasibility Study and Nested Qualitative Analysis","Inclusion Criteria:\n\n* Adult female patients scheduled for planned abdominal surgery for gynecologic or gynecologic-oncologic indications.\n\nIdentification as \"high-risk\" for wound healing complications based on a clinical risk screening at admission.\n\nSigned informed consent.\n\nExclusion Criteria:\n\n* Failure to provide informed consent.","FEMALE","18 Years",{"count":19,"type":20},30,"ESTIMATED","INTERVENTIONAL",[23],"NA","This is a prospective, open-label, non-randomized interventional feasibility study with a nested qualitative analysis. The study exploratively verifies the feasibility of targeted prophylactic closed incision negative pressure wound therapy (ciNPWT) in clinical practice for patients with a high predicted risk of wound healing complications and compares the 30-day incidence of postoperative complications with standard dressing.\n\nParticipants will:\n\n* Get ciNPWT or standard dressing after planned laparotomy\n* Answer the questionairs about qualite of life\n* Will visit the clinic 30 days after surgery to see the final result",[26,27,28,29,30],"Surgical Site Infection (SSI)","Wound Healing Complication","Seroma","Hematoma","Dehiscence",[32,33,34,35,36,37,38],"ciNPWT","laparotomy","surgical site infection","SSI","feasibility","PROMs","ASEPSIS","NOT_YET_RECRUITING","2026-06-11",{"date":42,"type":43},"2026-06-12","ACTUAL",{"date":45,"type":20},"2026-07",{"date":47,"type":20},"2028-12",{"name":49,"class":50},"University Hospital Hradec Kralove","OTHER",{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":58,"sex":59,"minAge":17,"maxAge":60,"enrollmentInfo":61,"targetDuration":4,"studyType":21,"phases":63,"briefSummary":65,"conditions":66,"keywords":72,"overallStatus":79,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":5},"100576921","phase-4-bridging-the-healing-gap-a-single-blind-clinical-trial-assessing-the-efficacy-of-carboxy-gel-in-reducing-bruising-and-pain-post-liposuction-100576921","NCT06791577","Bridging the Healing Gap: A Single-Blind Clinical Trial Assessing the Efficacy of Carboxy-gel in Reducing Bruising and Pain Post-Liposuction","CO2L001","Inclusion Criteria:\n\n* Patients undergoing body contouring procedures (liposuction or liposculpture), either individually or combined with a maximum of two other major aesthetic procedures involving face, breast, or dermo-lipectomy.\n* healthy patients without underlying comorbidities (classified as ASA≤II)\n\nExclusion Criteria:\n\n* Pregnant patients\n* Known allergy to CO2 Lift or Vaseline\n* History of keloid formation or significant dermatological conditions.\n* Coagulopathy or current use of anticoagulant therapy.\n* Skin disorders related to collagen disease.\n* BMI ≥ 32 kg\u002Fm2.",true,"ALL","65 Years",{"count":62,"type":20},50,[64],"PHASE4","The goal of this clinical trial is to evaluate if CO2 Lift reduces bruising and pain after Liposuction. The study also aims to explore changes in patient satisfaction. The main questions this study seeks to answer are:\n\n* Does CO2 lift reduce the extent of bruising at 7 days post-surgery?\n* How does CO2 lift impact patient-reported pain and satisfaction?\n\nIn this study, researchers will compare CO2 lift to a placebo (Vaseline) to see if the intervention has a positive effect.\n\nThe study procedures include:\n\n* Baseline data collection of sociodemographic variables. Data collection of surgical variables, adverse events, pain scores, and satisfaction scores.\n* During the liposuction procedure the patient will receive CO2 Lift application to one arm, and\u002For one glute, and\u002For one half of the lower abdomen, and placebo (Vaseline) to the contralateral part.\n* Apply CO2 lift and Vaseline immediately after surgery, 12 hours later, and then once a day for 3 to 5 days depending of the risk of the flap\u002Fskin.\n* Postoperative follow-up with photos of treated areas at 24 hours, 3 days, and 7 days, with bruising quantified using Image J software.",[67,68,69,70,71,29],"Liposuction","Bruising","Inflammation","Pain, Postoperative","Ecchymosis",[73,74,75,67,76,77,78],"Carboxytherapy","CO2 Lift","Body contouring","Liposculpture","High Definition Liposculpture","Patient outcomes","RECRUITING","2025-04-27",{"date":82,"type":43},"2025-04-30",{"date":84,"type":43},"2023-09-01",{"date":86,"type":20},"2025-12-15",{"name":88,"class":50},"Total Definer Research Group",{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":11,"sex":59,"minAge":17,"maxAge":4,"enrollmentInfo":97,"targetDuration":4,"studyType":21,"phases":99,"briefSummary":100,"conditions":101,"keywords":104,"overallStatus":79,"whyStopped":4,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":115},"100319307","maintenance-of-an-antiaggregation-by-acetylsalicylic-acid-while-a-extracorporeal-lithotripsy-session-on-a-kidney-stone-is-perfomed-comparative-unicentric-prospective-study-100319307","NCT03437057","Maintenance of an Antiaggregation by Acetylsalicylic Acid, While a Extracorporeal Lithotripsy Session on a Kidney Stone is Perfomed: Comparative Unicentric Prospective Study","Maintenance of an Antiaggregation by Acetylsalicylic Acid, Less or Equal to 250mg While a Extracorporeal Lithotripsy (ECL) Session on a Kidney Stone is Perfomed: Comparative Unicentric Prospective Study","KARLITHO","Inclusion Criteria\n\n* Over 18 yo patients\n* Patients with 1 renal lithiasis (at least) requiring treatment with extracorporeal lithotripsy\n* Patients taking Kardégic 75 (monotherapy\n\nExclusion Criteria:\n\n* Patients with known (or previously known) bleeding disorders on the pre-treatment assessment\n* Patients with anticoagulant therapy or other anti-aggregating therapy (eg Kardegic at 75mg, AVK, NACO, LMWH, HNF, P2Y12 inhibitor)\n* Patients with another contrindication to the ECL.\n* Patients with prescription of more than the outset 1 ECL session\n* Tutelage, curatorship, justice safeguarding, deprived of liberties, unaffiliated SS, impaired comprehension abilities, pregnant and lactating women.",{"count":98,"type":20},300,[23],"Background\u002FRationale for the study:\n\nLithiasis pathology is increasingly common because of the change in our lifestyle and our food. Thus, we hold a prevalence for urinary lithiasis 10% in France currently including 13% of the male population and 6% of the female population.\n\nThe formation of urinary lithiasis is the result of a complex mechanism involving factors anatomical and infectious metabolics. They are classified according to their size, topography and composition.\n\nThe treatment of urinary lithiasis has changed dramatically in recent years. The recommendations of the French Urology Association (AFU) for the management of kidney stones and ureteral of the adult of 2004 give a certain place to the treatment by extracorporeal lithotripsy (ECL).\n\nThe ELC is indicated for the first purpose for lithiasis ureteral or renal lithiasis of less than 20 mm, whether or not associated with the setting up of a JJ stent. For kidney stones of more than 20 mm or complex or Coralliformes, the ECL can be associated with treatment with percutaneous nephrolithotomy. In addition, the ECL is indicated in case of residual cholelithiasis 3 months after a first treatment whatsoever.\n\nIt is found, as the main complication of the ECL, a risk of the appearance of Hematomas under capsular, peri-renal and intra-parenchymatous. Its prevalence is estimated to be between 6.2% and 13% according to studies.\n\nACETYLSALICYLIC ACID less or equal to 250 mg is the usual dosage of aspirin (for the adult), the Marketing Autorisation recognises in secondary prevention after a first myocardial or cerebral ischemic attack related to atherosclerosis. It entrains a reduction mortality and morbidity of cardiovascular causes.\n\nAcetylsalicylic acid is currently being stopped 5 to 7 days before the ECL. The interest of maintaining the Acetylsalicylic acid is:\n\n* A simplification of the management of patients under on acetylsalicylic acid below (or equal to) 250 mg (No modification of Treatment to be implemented)\n* A cardiovascular risk decreased by maintaining their initial treatment without any modification.\n\nMain objective:\n\nEvaluation of the proportion of renal hematoma during the production of Lithotripsy for renal lithiasis, on a 15-day scan, in patients under on acetylsalicylic acid below (or equal to) 250 mg not stopped\n\nSecondary objectives:\n\nEvaluation of the efficacy of treatment with lithotripsy (Stone free, fragments Minimal residuals) Evaluation of the proportion of hematuria macroscopic post lithotripsy in Patients under on acethylsalicylic acid not stopped. Evaluate the rate of post-ECL complications requiring treatment, Analgesic, obstructive pyelonephritis.\n\nEvaluate post-ECL pain due to hematoma or lithiasis migration Evaluation of the evolution of renal function post session of Lithotripsy on the patients under acethylsalicylic acid not stopped.\n\nType of Study: Interventional study, prospective, mono centric, single-arm",[102,103,29],"Renal Lithiasis","Antiplatelet",[105,29,103],"ECL","2025-01-16",{"date":108,"type":43},"2025-01-17",{"date":110,"type":43},"2018-01-08",{"date":112,"type":20},"2027-03",{"name":114,"class":50},"University Hospital, Clermont-Ferrand",1]